US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apogee Therapeutics

70.00

+0.91001.32%

Pre-market: 70.000.00000.00%08:41 EST

Volume:957.54K

Turnover:66.70M

Market Cap:4.78B

PE:-16.05

High:70.30

Open:68.23

Low:66.00

Close:69.09

52wk High:84.56

52wk Low:26.20

Shares:68.32M

Float Shares:47.47M

Volume Ratio:1.44

T/O Rate:2.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.3614

EPS(LYR):-3.3001

ROE:-38.41%

ROA:-25.26%

PB:8.16

PE(LYR):-21.21

Loading ...

Overview Company News Filings

RBC Downgrades Apogee Therapeutics to Sector Perform From Outperform, Raises Price Target to $83 From $70, Keeps Speculative Risk

MT Newswires Live

Apogee Therapeutics downgraded to Sector Perform from Outperform at RBC Capital

Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and GoodRx Holdings (GDRX)

Apogee Therapeutics CEO Michael Thomas Henderson Reports Disposal of Common Shares

Funding for Risky Biotechs Is Returning -- WSJ

Apogee Therapeutics Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares

Apogee Therapeutics Initiated at Peer Perform by Wolfe Research

UBS Initiates Apogee Therapeutics at Buy With $100 Price Target

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla

Apogee Therapeutics Inc : Btig Raises Target Price to $137 From $128

THOMSON REUTERS

BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin

BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge

Apogee Therapeutics Shares Add 1.7% Premarket After Asthma Drug Shows Promise in Early Trial

THOMSON REUTERS

BUZZ-Apogee Therapeutics rises as asthma drug shows promise in early trial

Apogee Therapeutics Announces Positive Interim Results From Phase 1B Trial of Zumilokibart (Apg777), Its Potentially Best-in-Class Anti-Il-13 Antibody, in Patients With Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook

THOMSON REUTERS

Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook

U.S. RESEARCH ROUNDUP-Brunswick, Parker-Hannifin, XPLR Infrastructure

Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026

Apogee Therapeutics Is Maintained at Buy by BTIG

Apogee Therapeutics CFO Jane Henderson Reports Disposal of Common Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/APGE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","market":"US","secType":"STK","nameCN":"Apogee Therapeutics","latestPrice":70,"timestamp":1772226000000,"preClose":69.09,"halted":0,"volume":957541,"hourTrading":{"tag":"盘前","latestPrice":70,"preClose":70,"latestTime":"08:41 EST","volume":5460,"amount":381666.3396,"timestamp":1772458883345,"change":0,"changeRate":0,"amplitude":0.018571},"delay":0,"changeRate":0.013171225937183334,"floatShares":47471600,"shares":68320200,"eps":-4.361393,"marketStatus":"Pre-Mkt","change":0.91,"latestTime":"03-02 08:50:22 EST","open":68.23,"high":70.3,"low":66,"amount":66696177.7976,"amplitude":0.062238,"askPrice":75.98,"askSize":100,"bidPrice":68,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-4.361393,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1772461800000},"marketStatusCode":1,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":70,"preHourTrading":{"tag":"盘前","latestPrice":70,"preClose":70,"latestTime":"08:41 EST","volume":5460,"amount":381666.3396,"timestamp":1772458883345,"change":0,"changeRate":0,"amplitude":0.018571},"postHourTrading":{"tag":"盘后","latestPrice":70,"preClose":70,"latestTime":"16:49 EST","volume":23184,"amount":1622973.4162,"timestamp":1772228960891,"change":0,"changeRate":0,"amplitude":0.007714},"volumeRatio":1.4356485367977023,"impliedVol":0.8579,"impliedVolPercentile":0.68},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APGE\",,,,,undefined,":{"symbol":"APGE","floatShares":47471600,"roa":"-25.26%","roe":"-38.41%","lyrEps":-3.300106,"volumeRatio":1.4356485367977023,"shares":68320200,"dividePrice":0,"high":70.3,"amplitude":0.062238,"preClose":69.09,"low":66,"week52Low":26.2,"pbRate":"8.16","week52High":84.56,"institutionHeld":0,"latestPrice":70,"eps":-4.361393,"divideRate":0,"volume":957541,"delay":0,"ttmEps":-4.361393,"open":68.23,"prevYearClose":75.48,"prevWeekClose":70,"prevMonthClose":70,"prevQuarterClose":75.48,"fiveDayClose":68.39,"twentyDayClose":69.98,"sixtyDayClose":68.96},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APGE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-10","symbol":"APGE","fiscalQuarterEnding":"2025/09","expectedEps":-1.14,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762750800000,"reportTimeType":"pre","actualEps":-1.11},{"market":"US","date":"2025-08-11","symbol":"APGE","fiscalQuarterEnding":"2025/06","expectedEps":-1.03,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.13},{"market":"US","date":"2025-05-12","symbol":"APGE","fiscalQuarterEnding":"2025/03","expectedEps":-1.19,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-0.95},{"market":"US","date":"2025-03-03","symbol":"APGE","fiscalQuarterEnding":"2024/12","expectedEps":-0.94,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-1.19},{"market":"US","date":"2024-11-12","symbol":"APGE","fiscalQuarterEnding":"2024/09","expectedEps":-0.73,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.86}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APGE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.375,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.375,"analysts":16,"updateTime":1769662800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APGE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APGE","date":"2026-02-27","current":-16.049918,"percent":0.464567,"low":-42.099968,"twenty":-25.237859,"median":-17.924865,"eighty":-11.971712,"high":-8.51736,"avg":-19.112079,"sd":7.606095,"marketCap":4662762501},"quantilePoints":[{"date":"2023-07-14","current":-14.120082,"twenty":-14.120082,"median":-14.120082,"eighty":-14.120082,"marketCap":728904256},{"date":"2023-07-21","current":-18.011929,"twenty":-18.356106,"median":-18.157543,"eighty":-18.011929,"marketCap":929808491},{"date":"2023-07-28","current":-20.899222,"twenty":-20.280785,"median":-18.735584,"eighty":-18.04723,"marketCap":1078855761},{"date":"2023-08-04","current":-20.732342,"twenty":-20.732342,"median":-20.114656,"eighty":-18.267856,"marketCap":1070241131},{"date":"2023-08-11","current":-21.547107,"twenty":-20.865853,"median":-20.262175,"eighty":-18.356106,"marketCap":1112300797},{"date":"2023-08-18","current":-23.166822,"twenty":-21.272247,"median":-20.482022,"eighty":-18.735584,"marketCap":1195913385},{"date":"2023-08-25","current":-24.246631,"twenty":-22.764347,"median":-20.836643,"eighty":-19.947026,"marketCap":1251655111},{"date":"2023-09-01","current":-16.923199,"twenty":-22.901778,"median":-20.784492,"eighty":-18.356106,"marketCap":1162468350},{"date":"2023-09-08","current":-17.424846,"twenty":-22.791833,"median":-20.482022,"eighty":-18.04017,"marketCap":1196926871},{"date":"2023-09-15","current":-15.33711,"twenty":-22.261745,"median":-20.262175,"eighty":-17.454355,"marketCap":1053518613},{"date":"2023-09-22","current":-15.742854,"twenty":-21.87694,"median":-20.07464,"eighty":-16.946806,"marketCap":1081389476},{"date":"2023-09-29","current":-15.255962,"twenty":-21.600116,"median":-18.735584,"eighty":-16.181057,"marketCap":1047944441},{"date":"2023-10-06","current":-15.816626,"twenty":-21.327219,"median":-18.248406,"eighty":-15.736952,"marketCap":1086456906},{"date":"2023-10-13","current":-14.754315,"twenty":-21.232981,"median":-18.011929,"eighty":-15.43744,"marketCap":1013485920},{"date":"2023-10-20","current":-14.732183,"twenty":-21.097514,"median":-17.509684,"eighty":-15.343012,"marketCap":1011965691},{"date":"2023-10-27","current":-11.065736,"twenty":-21.032725,"median":-17.443289,"eighty":-15.295798,"marketCap":760114440},{"date":"2023-11-03","current":-13.714136,"twenty":-20.892548,"median":-17.107628,"eighty":-15.064155,"marketCap":942035162},{"date":"2023-11-10","current":-11.751812,"twenty":-20.860011,"median":-16.901067,"eighty":-14.764643,"marketCap":807241535},{"date":"2023-11-17","current":-12.191046,"twenty":-20.815783,"median":-16.340404,"eighty":-14.242502,"marketCap":851834915},{"date":"2023-11-24","current":-12.473884,"twenty":-20.732342,"median":-15.9863,"eighty":-13.271633,"marketCap":871597891},{"date":"2023-12-01","current":-14.149156,"twenty":-20.643994,"median":-15.77974,"eighty":-12.959786,"marketCap":988655514},{"date":"2023-12-08","current":-15.76641,"twenty":-20.320051,"median":-15.713345,"eighty":-13.06857,"marketCap":1101659195},{"date":"2023-12-15","current":-16.854248,"twenty":-20.280785,"median":-15.705968,"eighty":-13.227243,"marketCap":1177670639},{"date":"2023-12-22","current":-18.52952,"twenty":-20.262175,"median":-15.76641,"eighty":-13.271633,"marketCap":1294728262},{"date":"2023-12-29","current":-21.77128,"twenty":-20.316166,"median":-15.824003,"eighty":-13.537135,"marketCap":1521242365},{"date":"2024-01-05","current":-20.48763,"twenty":-20.454114,"median":-15.9863,"eighty":-13.786432,"marketCap":1431548862},{"date":"2024-01-12","current":-23.098443,"twenty":-20.721111,"median":-16.285075,"eighty":-14.084509,"marketCap":1613976327},{"date":"2024-01-19","current":-23.34502,"twenty":-20.899222,"median":-16.57141,"eighty":-14.120082,"marketCap":1631205588},{"date":"2024-01-26","current":-26.1734,"twenty":-21.423171,"median":-16.854248,"eighty":-14.149156,"marketCap":1828835342},{"date":"2024-02-02","current":-24.650426,"twenty":-22.136094,"median":-16.901067,"eighty":-14.410237,"marketCap":1722419321},{"date":"2024-02-09","current":-26.833356,"twenty":-22.901778,"median":-17.107628,"eighty":-14.722084,"marketCap":1874948952},{"date":"2024-02-16","current":-25.919571,"twenty":-23.170966,"median":-17.443289,"eighty":-14.732183,"marketCap":1811099339},{"date":"2024-02-23","current":-25.462679,"twenty":-23.458155,"median":-17.594521,"eighty":-14.738085,"marketCap":1779174532},{"date":"2024-03-01","current":-25.252364,"twenty":-23.903055,"median":-18.011929,"eighty":-14.745463,"marketCap":1764478986},{"date":"2024-03-08","current":-39.349598,"twenty":-24.476372,"median":-18.248406,"eighty":-14.75284,"marketCap":3304775976},{"date":"2024-03-15","current":-39.31944,"twenty":-25.034796,"median":-18.52952,"eighty":-14.795627,"marketCap":3302243192},{"date":"2024-03-22","current":-40.133695,"twenty":-25.237859,"median":-19.967125,"eighty":-14.977105,"marketCap":3370628348},{"date":"2024-03-28","current":-41.080642,"twenty":-25.310382,"median":-20.039026,"eighty":-15.024319,"marketCap":3450157751},{"date":"2024-04-05","current":-35.585933,"twenty":-25.583066,"median":-20.203754,"eighty":-15.040549,"marketCap":2988684589},{"date":"2024-04-12","current":-40.39061,"twenty":-25.977589,"median":-20.297181,"eighty":-15.087984,"marketCap":3392205375},{"date":"2024-04-19","current":-33.647243,"twenty":-26.134238,"median":-20.48763,"eighty":-15.119386,"marketCap":2825863713},{"date":"2024-04-26","current":-30.802638,"twenty":-26.87687,"median":-20.704265,"eighty":-15.154157,"marketCap":2586959527},{"date":"2024-05-03","current":-35.061005,"twenty":-31.417884,"median":-20.865853,"eighty":-15.223502,"marketCap":2944598502},{"date":"2024-05-10","current":-35.544605,"twenty":-33.702281,"median":-21.144633,"eighty":-15.273667,"marketCap":2985213654},{"date":"2024-05-17","current":-30.341768,"twenty":-33.2059,"median":-21.423171,"eighty":-15.316454,"marketCap":3142011451},{"date":"2024-05-24","current":-25.989488,"twenty":-32.751748,"median":-21.791716,"eighty":-15.341537,"marketCap":2691315483},{"date":"2024-05-31","current":-26.170128,"twenty":-32.249341,"median":-22.218395,"eighty":-15.347905,"marketCap":2710021411},{"date":"2024-06-07","current":-23.773834,"twenty":-31.497141,"median":-22.764347,"eighty":-15.361417,"marketCap":2461875577},{"date":"2024-06-14","current":-24.341154,"twenty":-31.168024,"median":-22.917136,"eighty":-15.378422,"marketCap":2520623884},{"date":"2024-06-21","current":-21.479149,"twenty":-30.802638,"median":-22.901778,"eighty":-15.396128,"marketCap":2224251827},{"date":"2024-06-28","current":-22.551696,"twenty":-30.67474,"median":-22.901778,"eighty":-15.416784,"marketCap":2335318278},{"date":"2024-07-05","current":-21.168675,"twenty":-30.454668,"median":-22.551696,"eighty":-15.452028,"marketCap":2192101012},{"date":"2024-07-12","current":-25.927394,"twenty":-30.290963,"median":-22.599678,"eighty":-15.490824,"marketCap":2684885320},{"date":"2024-07-15","current":-27.107194,"twenty":-30.240158,"median":-22.64766,"eighty":-15.512581,"marketCap":2807058416},{"date":"2024-08-02","current":-25.825784,"twenty":-30.189354,"median":-22.706004,"eighty":-15.534337,"marketCap":2674363235},{"date":"2024-08-09","current":-22.78314,"twenty":-29.894686,"median":-22.901778,"eighty":-15.586554,"marketCap":2359285249},{"date":"2024-08-16","current":-22.360657,"twenty":-29.660984,"median":-22.773744,"eighty":-15.598555,"marketCap":2649402436},{"date":"2024-08-23","current":-23.604561,"twenty":-29.231009,"median":-22.862169,"eighty":-15.66023,"marketCap":2796786413},{"date":"2024-08-30","current":-24.399278,"twenty":-28.636347,"median":-22.994085,"eighty":-15.707443,"marketCap":2890948398},{"date":"2024-09-06","current":-23.811878,"twenty":-28.151516,"median":-23.098851,"eighty":-15.725149,"marketCap":2821350409},{"date":"2024-09-13","current":-24.28081,"twenty":-27.512504,"median":-23.170966,"eighty":-15.752276,"marketCap":2876911828},{"date":"2024-09-20","current":-26.136794,"twenty":-27.110581,"median":-23.268758,"eighty":-15.786496,"marketCap":3096818079},{"date":"2024-09-27","current":-28.649283,"twenty":-28.484417,"median":-23.34502,"eighty":-15.822528,"marketCap":3394510318},{"date":"2024-10-04","current":-28.061884,"twenty":-28.569318,"median":-23.434542,"eighty":-15.893348,"marketCap":3324912329},{"date":"2024-10-11","current":-26.610663,"twenty":-28.484417,"median":-23.533922,"eighty":-16.011479,"marketCap":3152964356},{"date":"2024-10-18","current":-27.755844,"twenty":-28.448831,"median":-23.612583,"eighty":-16.121447,"marketCap":3288651192},{"date":"2024-10-25","current":-25.643182,"twenty":-28.355515,"median":-23.773834,"eighty":-16.274009,"marketCap":3038332374},{"date":"2024-10-31","current":-27.099339,"twenty":-28.252419,"median":-23.811878,"eighty":-16.385155,"marketCap":3210865204},{"date":"2024-11-08","current":-28.654219,"twenty":-28.465143,"median":-23.860074,"eighty":-16.567059,"marketCap":3395095175},{"date":"2024-11-15","current":-19.789128,"twenty":-28.485404,"median":-23.853973,"eighty":-16.630879,"marketCap":2902332924},{"date":"2024-11-22","current":-16.628998,"twenty":-28.465143,"median":-23.803477,"eighty":-16.671147,"marketCap":2438858722},{"date":"2024-11-29","current":-17.517481,"twenty":-28.399895,"median":-23.76973,"eighty":-16.839744,"marketCap":2569166386},{"date":"2024-12-06","current":-18.297329,"twenty":-28.288946,"median":-23.604561,"eighty":-16.854248,"marketCap":2683541235},{"date":"2024-12-13","current":-17.195455,"twenty":-28.106309,"median":-23.497667,"eighty":-16.861788,"marketCap":2521936971},{"date":"2024-12-20","current":-18.243012,"twenty":-28.061884,"median":-23.417542,"eighty":-16.878936,"marketCap":2675574828},{"date":"2024-12-27","current":-18.305089,"twenty":-28.042139,"median":-23.34502,"eighty":-16.878936,"marketCap":2684679293},{"date":"2025-01-03","current":-18.29345,"twenty":-27.898004,"median":-23.314068,"eighty":-16.905494,"marketCap":2682972206},{"date":"2025-01-10","current":-19.092697,"twenty":-27.799282,"median":-23.175118,"eighty":-16.935003,"marketCap":2800192201},{"date":"2025-01-17","current":-14.239016,"twenty":-27.785817,"median":-23.13304,"eighty":-16.857264,"marketCap":2088336797},{"date":"2025-01-24","current":-15.60084,"twenty":-27.774326,"median":-23.084739,"eighty":-16.58873,"marketCap":2288066011},{"date":"2025-01-31","current":-16.489324,"twenty":-27.755844,"median":-22.901778,"eighty":-16.251878,"marketCap":2418373675},{"date":"2025-02-07","current":-16.155657,"twenty":-27.743997,"median":-22.822654,"eighty":-16.03771,"marketCap":2369437172},{"date":"2025-02-14","current":-14.068303,"twenty":-27.666994,"median":-22.64766,"eighty":-15.83959,"marketCap":2063299516},{"date":"2025-02-21","current":-13.17206,"twenty":-27.548527,"median":-22.532767,"eighty":-15.742854,"marketCap":1931853794},{"date":"2025-02-28","current":-11.845154,"twenty":-27.262231,"median":-22.345048,"eighty":-15.697836,"marketCap":1737245842},{"date":"2025-03-07","current":-11.30201,"twenty":-27.112839,"median":-22.212997,"eighty":-15.60472,"marketCap":2058615932},{"date":"2025-03-14","current":-12.223647,"twenty":-27.107194,"median":-21.977899,"eighty":-15.577851,"marketCap":2226488393},{"date":"2025-03-21","current":-12.874214,"twenty":-27.104275,"median":-21.832491,"eighty":-15.410728,"marketCap":2344986602},{"date":"2025-03-28","current":-12.51704,"twenty":-27.099339,"median":-21.774807,"eighty":-15.344488,"marketCap":2279928762},{"date":"2025-04-04","current":-11.158503,"twenty":-27.089467,"median":-21.479149,"eighty":-15.267174,"marketCap":2032476621},{"date":"2025-04-11","current":-9.54803,"twenty":-27.02252,"median":-21.347709,"eighty":-15.123173,"marketCap":1739135468},{"date":"2025-04-17","current":-10.217731,"twenty":-27.018004,"median":-21.19592,"eighty":-15.044975,"marketCap":1861118918},{"date":"2025-04-25","current":-11.815448,"twenty":-27.009303,"median":-21.066101,"eighty":-14.75284,"marketCap":2152136576},{"date":"2025-05-02","current":-12.501095,"twenty":-26.955194,"median":-20.851248,"eighty":-14.659715,"marketCap":2277024394},{"date":"2025-05-09","current":-12.057816,"twenty":-26.905994,"median":-20.676189,"eighty":-14.171382,"marketCap":2196282968},{"date":"2025-05-16","current":-11.538128,"twenty":-26.893009,"median":-20.509211,"eighty":-14.009329,"marketCap":2369827680},{"date":"2025-05-23","current":-11.469666,"twenty":-26.845089,"median":-20.320051,"eighty":-13.400194,"marketCap":2355766140},{"date":"2025-05-30","current":-10.709474,"twenty":-26.800437,"median":-20.280785,"eighty":-13.20517,"marketCap":2199629509},{"date":"2025-06-06","current":-10.699527,"twenty":-26.74614,"median":-20.193343,"eighty":-12.998374,"marketCap":2197586600},{"date":"2025-06-13","current":-11.895942,"twenty":-26.656227,"median":-20.052494,"eighty":-12.887608,"marketCap":2443319391},{"date":"2025-06-20","current":-11.702697,"twenty":-26.554695,"median":-19.987224,"eighty":-12.832982,"marketCap":2403628584},{"date":"2025-06-27","current":-12.450101,"twenty":-26.451682,"median":-19.588347,"eighty":-12.738391,"marketCap":2557138617},{"date":"2025-07-03","current":-13.487372,"twenty":-26.404333,"median":-19.162534,"eighty":-12.723904,"marketCap":2770184861},{"date":"2025-07-11","current":-10.960977,"twenty":-26.318444,"median":-18.921984,"eighty":-12.668332,"marketCap":2251285927},{"date":"2025-07-18","current":-11.083176,"twenty":-26.254685,"median":-18.735668,"eighty":-12.572137,"marketCap":2276384526},{"date":"2025-07-25","current":-11.833421,"twenty":-26.172746,"median":-18.534,"eighty":-12.51704,"marketCap":2430478247},{"date":"2025-08-01","current":-10.872879,"twenty":-26.165436,"median":-18.435064,"eighty":-12.454858,"marketCap":2233191588},{"date":"2025-08-08","current":-10.230624,"twenty":-26.144692,"median":-18.356106,"eighty":-12.348931,"marketCap":2101278024},{"date":"2025-08-15","current":-9.370325,"twenty":-26.131061,"median":-18.310909,"eighty":-12.239332,"marketCap":2227054492},{"date":"2025-08-22","current":-8.957767,"twenty":-26.099427,"median":-18.29345,"eighty":-12.125473,"marketCap":2129001470},{"date":"2025-08-29","current":-9.024303,"twenty":-26.061716,"median":-18.235984,"eighty":-12.057962,"marketCap":2144815236},{"date":"2025-09-05","current":-9.149983,"twenty":-26.050112,"median":-18.048125,"eighty":-11.971712,"marketCap":2174685683},{"date":"2025-09-12","current":-9.184484,"twenty":-25.999346,"median":-17.978348,"eighty":-11.914309,"marketCap":2182885414},{"date":"2025-09-19","current":-9.470344,"twenty":-25.989488,"median":-17.837569,"eighty":-11.833421,"marketCap":2250826038},{"date":"2025-09-26","current":-9.246091,"twenty":-25.963085,"median":-17.587319,"eighty":-11.751667,"marketCap":2197527790},{"date":"2025-10-03","current":-9.761132,"twenty":-25.927394,"median":-17.537558,"eighty":-11.64586,"marketCap":2319938053},{"date":"2025-10-10","current":-13.112594,"twenty":-25.927394,"median":-17.474803,"eighty":-11.60039,"marketCap":3116483307},{"date":"2025-10-17","current":-14.719201,"twenty":-25.919571,"median":-17.381927,"eighty":-11.6264,"marketCap":3498327236},{"date":"2025-10-24","current":-14.83497,"twenty":-25.825784,"median":-17.31961,"eighty":-11.641401,"marketCap":3525842169},{"date":"2025-10-31","current":-15.446892,"twenty":-25.767274,"median":-17.151542,"eighty":-11.64586,"marketCap":3671278245},{"date":"2025-11-07","current":-15.158848,"twenty":-25.763689,"median":-17.013102,"eighty":-11.649617,"marketCap":3602818471},{"date":"2025-11-14","current":-16.75274,"twenty":-25.752769,"median":-16.901067,"eighty":-11.702697,"marketCap":4249734472},{"date":"2025-11-21","current":-16.859157,"twenty":-25.643182,"median":-16.952708,"eighty":-11.751008,"marketCap":4276729768},{"date":"2025-11-28","current":-19.147128,"twenty":-25.58,"median":-17.00282,"eighty":-11.751535,"marketCap":4857128632},{"date":"2025-12-05","current":-20.086261,"twenty":-25.516057,"median":-17.081704,"eighty":-11.751783,"marketCap":5095362120},{"date":"2025-12-12","current":-20.360285,"twenty":-25.476749,"median":-17.24758,"eighty":-11.795704,"marketCap":5164875007},{"date":"2025-12-19","current":-20.578441,"twenty":-25.464129,"median":-17.327965,"eighty":-11.813694,"marketCap":5220215364},{"date":"2025-12-26","current":-20.775313,"twenty":-25.437705,"median":-17.381927,"eighty":-11.826232,"marketCap":5270156661},{"date":"2026-01-02","current":-20.08094,"twenty":-25.407235,"median":-17.443781,"eighty":-11.835695,"marketCap":5094012355},{"date":"2026-01-09","current":-20.613026,"twenty":-25.376631,"median":-17.517481,"eighty":-11.841525,"marketCap":5228988835},{"date":"2026-01-16","current":-21.482988,"twenty":-25.344147,"median":-17.566657,"eighty":-11.865469,"marketCap":5449675380},{"date":"2026-01-23","current":-21.246209,"twenty":-25.316184,"median":-17.607671,"eighty":-11.899615,"marketCap":5389610846},{"date":"2026-01-30","current":-18.617702,"twenty":-25.310382,"median":-17.773551,"eighty":-11.916319,"marketCap":4722827035},{"date":"2026-02-06","current":-16.529263,"twenty":-25.299938,"median":-17.629714,"eighty":-11.92777,"marketCap":4193044351},{"date":"2026-02-13","current":-18.439453,"twenty":-25.257004,"median":-17.587319,"eighty":-11.943328,"marketCap":4677609914},{"date":"2026-02-20","current":-18.338357,"twenty":-25.252364,"median":-17.631406,"eighty":-11.950995,"marketCap":4651964383},{"date":"2026-02-27","current":-18.380924,"twenty":-25.237859,"median":-17.924865,"eighty":-11.971712,"marketCap":4662762501}],"updateTime":1772447811819},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APGE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2605498383","title":"RBC Downgrades Apogee Therapeutics to Sector Perform From Outperform, Raises Price Target to $83 From $70, Keeps Speculative Risk","url":"https://stock-news.laohu8.com/highlight/detail?id=2605498383","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605498383?lang=en_us&edition=fundamental","pubTime":"2026-01-22 19:20","pubTimestamp":1769080824,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (APGE) has an average rating of buy and mean price target of $104.43, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"gpt_icon":0},{"id":"2605467662","title":"Apogee Therapeutics downgraded to Sector Perform from Outperform at RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605467662","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605467662?lang=en_us&edition=fundamental","pubTime":"2026-01-22 18:20","pubTimestamp":1769077211,"startTime":"0","endTime":"0","summary":"RBC Capital downgraded Apogee Therapeutics (APGE) to Sector Perform from Outperform with a price target of $83, up from $70. The firm cites valuati...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-downgraded-to-sector-perform-from-outperform-at-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apogee-therapeutics-downgraded-to-sector-perform-from-outperform-at-rbc-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APGE"],"gpt_icon":0},{"id":"2604823571","title":"Analysts Offer Insights on Healthcare Companies: Apogee Therapeutics (APGE) and GoodRx Holdings (GDRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2604823571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604823571?lang=en_us&edition=fundamental","pubTime":"2026-01-19 17:40","pubTimestamp":1768815626,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Apogee Therapeutics (APGE – Research Report) and G...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-goodrx-holdings-gdrx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-apogee-therapeutics-apge-and-goodrx-holdings-gdrx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0053671581.USD","LABU","BK4581","BK4585","LU0128526141.USD","BK4167","HCSG","XBI","BK4139","XLV","BK4137","APGE","LU0029874061.USD","BK4588","GDRX"],"gpt_icon":0},{"id":"2604910341","title":"Apogee Therapeutics CEO Michael Thomas Henderson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2604910341","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604910341?lang=en_us&edition=fundamental","pubTime":"2026-01-17 09:00","pubTimestamp":1768611657,"startTime":"0","endTime":"0","summary":"Michael Thomas Henderson, Chief Executive Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260117:nNDL8kqWMn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics CEO Michael Thomas Henderson Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU0053671581.USD","APGE"],"gpt_icon":0},{"id":"2603424785","title":"Funding for Risky Biotechs Is Returning -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2603424785","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603424785?lang=en_us&edition=fundamental","pubTime":"2026-01-13 01:00","pubTimestamp":1768237200,"startTime":"0","endTime":"0","summary":"Wall Street is opening its coffers again for risky drug developers.Many small biotechnology companies have struggled to raise money in recent years. Public markets were all but shut. Initial public offerings slowed to a trickle and follow-on share sales, used by already-public companies to raise more funding, were muted. Some biotechs shut down.Yet investors began writing more checks toward the end of last year, giving some firms much-needed funding to pay for their costly research.Drug developers and other life-sciences companies traded on U.S. exchanges raised more than $13 billion from issuing new stock in the fourth quarter, the most for any quarter since the second quarter of 2021, according to data from LSEG, a financial-data provider.Apogee Therapeutics, which is developing treatments for immune diseases, raised some $345 million from investors in October, more than its $300 million target.Funding is crucial for startups. They are often years away from producing any revenue from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4588","LU0053671581.USD","BK4139","BK4599","GPCR","DYN","BK4007","BK4505","BK4585"],"gpt_icon":0},{"id":"2602300486","title":"Apogee Therapeutics Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602300486","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602300486?lang=en_us&edition=fundamental","pubTime":"2026-01-10 09:00","pubTimestamp":1768006858,"startTime":"0","endTime":"0","summary":"Carl Dambkowski, Chief Medical Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 09, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260110:nNDL8XwKqC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics Chief Medical Officer Carl Dambkowski Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2601751802","title":"Apogee Therapeutics Initiated at Peer Perform by Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2601751802","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601751802?lang=en_us&edition=fundamental","pubTime":"2026-01-08 00:08","pubTimestamp":1767802080,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 07, 2026 11:08 ET (16:08 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2601280118","title":"UBS Initiates Apogee Therapeutics at Buy With $100 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2601280118","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601280118?lang=en_us&edition=fundamental","pubTime":"2026-01-07 22:39","pubTimestamp":1767796793,"startTime":"0","endTime":"0","summary":"Apogee Therapeutics (APGE) has an average rating of buy and mean price target of $103.14, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["APGE"],"gpt_icon":0},{"id":"2601817333","title":"BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2601817333","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601817333?lang=en_us&edition=fundamental","pubTime":"2026-01-07 02:50","pubTimestamp":1767725435,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, TeslaEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL6N3Y70M5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS","COP","TPG","CNX","AIG","APGE","EPAM","JXN","CRNX","EQIX","SG","CFG","STAA","UAA","REGN","AEVA","PUMP","LYFT","FIX","ALB","TFC","UAL","LUV","VRTX","IFF","IMSR","OS","ANGO","EAT","BAC","ACN","PNC","WMB","NTRS","VST","EXE","NEM","FGBI","BALL","NBP"],"gpt_icon":1},{"id":"2601574819","title":"Apogee Therapeutics Inc : Btig Raises Target Price to $137 From $128","url":"https://stock-news.laohu8.com/highlight/detail?id=2601574819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601574819?lang=en_us&edition=fundamental","pubTime":"2026-01-07 00:00","pubTimestamp":1767715224,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y70YF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LU0053671581.USD","APGE"],"gpt_icon":0},{"id":"2601819813","title":"BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin","url":"https://stock-news.laohu8.com/highlight/detail?id=2601819813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601819813?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:52","pubTimestamp":1767714720,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed MartinEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL6N3Y70VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","INTU","PNC","NEM","ACN","SHAK","GL","CDE","ANGO","ALB","ACRS","MCHP","STT","LMT","BK","EPAM","DLR","STAA","APGE","CFG","BAC","OS","VST","REGN","VRTX","AIG","BALL","TFC","AEVA","HL","NTRS","UAA","GILD","IMSR","ALKS","JXN","EQIX","CRNX","NBP","CORZ","FERG","GNPX","ZETA","IFF","O"],"gpt_icon":1},{"id":"2601180648","title":"BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2601180648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601180648?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:12","pubTimestamp":1767708743,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridgeEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL6N3Y70M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACRS","STT","VERX","HL","AIG","GILD","NVDU","APGE","CDE","NVD2.UK","ALMS","GNPX","JXN","BK","RTO.UK","CRNX","NVDS.UK","NVDX","ZETA","GL","O","UAA","REGN","AEVA","ALB","NVDY","MCHP","INTU","NVIW.SI","NVD3.UK","ALKS","VRTX","IFF","OS","ANGO","NVDS","HGT.UK","ACN","NTRS","AU","VST","FERG","NEM","BALL","NBP"],"gpt_icon":1},{"id":"2601899067","title":"Apogee Therapeutics Shares Add 1.7% Premarket After Asthma Drug Shows Promise in Early Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601899067","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601899067?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:29","pubTimestamp":1767698940,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4N3Y70OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0053671581.USD","BK4139","APGE"],"gpt_icon":0},{"id":"2601789977","title":"BUZZ-Apogee Therapeutics rises as asthma drug shows promise in early trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601789977","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601789977?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:26","pubTimestamp":1767698800,"startTime":"0","endTime":"0","summary":"BUZZ-Apogee Therapeutics rises as asthma drug shows promise in early trial** Shares of drug developer Apogee Therapeutics APGE.O rise 1.66% to $78.35 premarket** Co says its experimental drug zumilokibart showed strong results in an early-stage trial for adults with mild-to-moderate asthma** Zumilokibart cut airway inflammation in the adults - AGPE** Effect lasted up to 32 weeks after a single dose; no serious side effects reported, says co ** Co's zumilokibart also being tested for atopic dermatitis, a chronic skin condition - APGE** Apogee expects more trial data this year and aims to start late-stage studies next year** As of last close, stock up ~3% over the past year  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4N3Y70N9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139","LU0053671581.USD"],"gpt_icon":0},{"id":"2601896242","title":"Apogee Therapeutics Announces Positive Interim Results From Phase 1B Trial of Zumilokibart (Apg777), Its Potentially Best-in-Class Anti-Il-13 Antibody, in Patients With Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2601896242","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601896242?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:00","pubTimestamp":1767697200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA5XLFSB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APGE","LU0053671581.USD","BK4139"],"gpt_icon":0},{"id":"2601899300","title":"Apogee Therapeutics Announces Positive Interim Results from Phase 1b Trial of Zumilokibart (APG777), its Potentially Best-in-Class Anti-IL-13 Antibody, in Patients with Mild-to-Moderate Asthma and Highlights 2026 Anticipated Milestones and Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2601899300","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601899300?lang=en_us&edition=fundamental","pubTime":"2026-01-06 19:00","pubTimestamp":1767697200,"startTime":"0","endTime":"0","summary":"Phase 1b interim results of zumilokibart (APG777) in asthma demonstrated rapid and durable suppression of FeNO (key biomarker of Type 2 inflammation) through 16 weeks for all patients - Suppression of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/06/3213394/0/en/Apogee-Therapeutics-Announces-Positive-Interim-Results-from-Phase-1b-Trial-of-Zumilokibart-APG777-its-Potentially-Best-in-Class-Anti-IL-13-Antibody-in-Patients-with-Mild-to-Moderat.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APGE","BK4132","INN","BK4181","LU0053671581.USD","BK4218","AD"],"gpt_icon":0},{"id":"2601086401","title":"U.S. RESEARCH ROUNDUP-Brunswick, Parker-Hannifin, XPLR Infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2601086401","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601086401?lang=en_us&edition=fundamental","pubTime":"2026-01-06 15:53","pubTimestamp":1767686032,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Brunswick, Parker-Hannifin, XPLR InfrastructureJan 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL8N3Y7095:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALHC","IE00B5TLWC47.USD","BALL","ARVN","APGE","AJG","BC","BOW","LU2249611893.SGD","WMS","ACAD","BMY","ADAM","BIIB","BK4178","BK","NLY","BA","EAT","ALL","AVY","AMT","ALGT","BBBY","BLTE","AXSM","AEO","ALK","SGXZ23171101.USD","AGIO","BK4532","BBIO","AGNC","ALNY","BAC","BBWI","BRLT","LU2125154935.USD","LU0971096721.USD","ARCT","SG9999014005.SGD","BP","LU0757428866.USD","AAL","BKD","BKNG","BK4135","ALB","AIG","DRUG"],"gpt_icon":1},{"id":"2601379778","title":"Apogee Therapeutics to Host Conference Call to Report Interim Results from the Phase 1b Trial of APG777 in Patients with Mild-to-Moderate Asthma and 2026 Anticipated Milestones on January 6, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601379778","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601379778?lang=en_us&edition=fundamental","pubTime":"2026-01-06 05:01","pubTimestamp":1767646860,"startTime":"0","endTime":"0","summary":"Webcast to be held Tuesday, January 6th at 8:00 a.m. ETSAN FRANCISCO and BOSTON, Jan.  05, 2026  (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/05/3213173/0/en/Apogee-Therapeutics-to-Host-Conference-Call-to-Report-Interim-Results-from-the-Phase-1b-Trial-of-APG777-in-Patients-with-Mild-to-Moderate-Asthma-and-2026-Anticipated-Milestones-on-.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","APGE","HST","BK4181","BK4218","LU0053671581.USD","BK4139","BK4585"],"gpt_icon":0},{"id":"2601835018","title":"Apogee Therapeutics Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2601835018","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601835018?lang=en_us&edition=fundamental","pubTime":"2026-01-05 19:19","pubTimestamp":1767611940,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/APGE/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 05, 2026 06:19 ET (11:19 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE"],"gpt_icon":0},{"id":"2593442899","title":"Apogee Therapeutics CFO Jane Henderson Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2593442899","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593442899?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:00","pubTimestamp":1766538052,"startTime":"0","endTime":"0","summary":"Jane Henderson, Chief Financial Officer of Apogee Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apogee Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 23, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251224:nNDL49ZzQb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Apogee Therapeutics CFO Jane Henderson Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APGE","BK4139","LU0053671581.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":2,"totalSize":112,"code":"91000000","status":"200"}]}}